Hunan Jiudian Pharmaceutical repurchases shares worth over 100m yuan

Hunan Jiudian Pharmaceutical Company Limited (SZSE:300705) announced an update on its share repurchase program. As of October 31, 2025, the company has cumulatively repurchased 6,180,800 shares, representing 1.24% of its total share capital. The total transaction value amounted to RMB 100,031,244, excluding transaction fees. The repurchases were executed through centralized bidding on a dedicated securities account.

The repurchases were made at prices ranging from RMB 14.51 to RMB 18.44 per share. This progress aligns with the company’s resolution from its Fourth Board of Directors' Ninth Meeting on February 17, 2025. The initial plan authorized a repurchase of public shares using proprietary funds and a dedicated stock repurchase loan, with a total value between RMB 100,000,000 and RMB 150,000,000, and a maximum price of RMB 24.98 per share, intended for future equity incentive plans.

Hunan Jiudian Pharmaceutical stated that the repurchase activity adheres to relevant laws, regulations, and the company's established repurchase plan. The company intends to continue its share repurchase efforts within the specified timeframe, adapting to market conditions, and will fulfill its information disclosure obligations as required by regulatory guidelines.